Chronic administration of acyl-ghrelin was shown to be protective in a mouse model of Parkinson’s disease [12] and mice lacking both desacyl- and acyl-ghrelin (ghrelin KO mice) have enhanced neurodegeneration. Here, GHRL is linked to Parkinson disease.